about
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytesDiscovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencingFrequent mutation of histone-modifying genes in non-Hodgkin lymphomaBMI1: A Biomarker of Hematologic MalignanciesHow I treat HIV-associated lymphomaMicroRNAs in B-cells: from normal differentiation to treatment of malignanciesNext generation sequencing: new tools in immunology and hematologyNovel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive reviewLoss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma.Second-generation inhibitors of Bruton tyrosine kinaseSNPs Array Karyotyping in Non-Hodgkin LymphomaB-cell receptor signalling and its crosstalk with other pathways in normal and malignant cellsOncogenically active MYD88 mutations in human lymphomaThe copper chelator ATN-224 induces caspase-independent cell death in diffuse large B cell lymphomaInactivating mutations of acetyltransferase genes in B-cell lymphomaBeyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.A microarray platform-independent classification tool for cell of origin class allows comparative analysis of gene expression in diffuse large B-cell lymphomaMeasles virus entry through the signaling lymphocyte activation molecule governs efficacy of mantle cell lymphoma radiovirotherapy.Gene selection and cancer type classification of diffuse large-B-cell lymphoma using a bivariate mixture model for two-species data.Discovering subgroups of patients from DNA copy number data using NMF on compacted matrices.Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older.Phase II study of sorafenib in patients with relapsed or refractory lymphoma.Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis.GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features.Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control.c-Myc dysregulation is a co-transforming event for nuclear factor-κB activated B cells.The CBM signalosome: potential therapeutic target for aggressive lymphoma?C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies.Prognostic markers in peripheral T-cell lymphomaMetadherin interference inhibits proliferation and enhances chemo-sensitivity to doxorubicin in diffuse large B cell lymphoma.Analysis of the coding genome of diffuse large B-cell lymphomaCD99 expression and newly diagnosed diffuse large B-cell lymphoma treated with rituximab-CHOP immunochemotherapy.Congenital B cell lymphocytosis explained by novel germline CARD11 mutations.A tumour suppressor network relying on the polyamine-hypusine axis.Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A.Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphomaThe preclinical profile of crizotinib for the treatment of non-small-cell lung cancer and other neoplastic disorders.DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma.
P2860
Q24604581-7911287C-0B91-4120-81F3-D9407CD651C3Q24612248-F426D596-F47C-43D8-887A-EE622821C2A6Q24630610-F796A564-59BA-440F-9BFF-0F17A0347840Q26750676-EC038BEB-A9EC-407A-9946-30B3CF651CD1Q26821860-CF73C61B-1D1F-4B59-BF1A-EA95229AB645Q26824682-C6D9D071-D46E-4967-9264-91A42239A46AQ27025231-F29674F5-EA80-4FAA-ACE4-5F56C6B3B998Q27304386-4160AF32-F6D7-4B1F-832E-23E39447C01CQ27853399-580CACCD-914F-4C9D-B177-D22214140FE6Q28076118-48597257-82BA-4BC4-88FB-D62B1DCA6511Q28085444-8566B417-883A-4D08-9707-673C11FF6E71Q28245018-74212211-E86E-4DDE-AC40-C7E66403B7B5Q28301648-379A72FD-E5B7-4F91-8C6B-EEEC9B1A3289Q28389285-799B14DE-3501-41CD-AB17-4602F153AC64Q29031276-D317C756-BA4C-4D49-B169-E1FCF73DB8AEQ30275206-0508DCDC-2EB4-4EFE-BCD3-B2F460E427A2Q30485971-E38A919B-E291-44BE-A669-727A39B06940Q30557338-A80AD43F-D1D6-4516-8F15-DC7B6EEC221DQ30584472-ECC87037-B666-49E0-905A-ECB858A322DDQ30701692-0102EE7C-9439-48F9-A836-876FF9E53A0EQ33396833-D9578B4F-EC9F-4517-8AB8-339FE15B4697Q33401136-3E66EA82-3FEB-4851-9DA4-1CA80A7A2BB5Q33573515-C0910A34-A901-4839-AEE4-B28D87329B0EQ33585286-AAD1B621-D2AF-4A57-9BD1-F00BF6DBCB13Q33601156-3786AF1D-633A-4453-8357-DEF017AF70B0Q33727517-EB1A5CB8-858F-446E-BEC3-FE2AEBD9BA98Q33815997-9624727D-878D-47B1-9A38-B6D8FFD20903Q33840233-0E749F90-1D11-430F-ABCE-5231CBB40046Q33877471-0350CCD7-9AF5-4A33-BB59-9A13B628EAA9Q33893704-95197AE9-E4AB-4899-A644-006FB4A5C048Q34166857-CAADDF31-EB2C-4729-9BE7-4438F1EE6A51Q34167090-7918DC8D-3FDC-499E-8D0F-6DB6BF10FC71Q34205133-4969AC54-540A-432A-844A-14BEDBA22F11Q34292361-1DD816E8-6CB7-4040-B57F-2E38DCE24707Q34310172-D8806CDB-17E8-4818-B7A0-B1A183A15469Q34313461-9F86FDB8-73EE-410C-A802-950B6F70352EQ34335192-86C446E4-B742-4940-A37E-103B6FD66CB5Q34341934-4DBBB830-A0C3-4AC0-9E24-99714700AD0CQ34353920-8CF0F614-3400-4BCD-8239-96F719AE100AQ34360406-530443A0-1037-460B-A301-7F046C34405B
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Aggressive lymphomas
@ast
Aggressive lymphomas
@en
Aggressive lymphomas
@nl
type
label
Aggressive lymphomas
@ast
Aggressive lymphomas
@en
Aggressive lymphomas
@nl
prefLabel
Aggressive lymphomas
@ast
Aggressive lymphomas
@en
Aggressive lymphomas
@nl
P3181
P356
P1476
Aggressive lymphomas
@en
P2093
Georg Lenz
P304
P3181
P356
10.1056/NEJMRA0807082
P407
P577
2010-04-15T00:00:00Z